Founders & Investors Forum 2025 holds dialogue between investors & startups

Biopioneer India wins the Best Startup Pitch award

At the second edition of the BioStartUps event- Founders & Investors Forum 2025, held on 1st August 2025 at the CIDCO Convention Centre, Navi Mumbai, interesting pitches were shared by three startups- Clinexel; Biopioneer India, and SpineX, with a jury panel of four investors including Dr Amandeep Singh- Founder, Biostrateon; Suraj Nair- Deep Science Investor, Ankur Capital; Sandeep Daga- Founder, Nine Rivers Capital; and Mayuresh Deosthale- Founder, NEXG2EN CFO LLP.

Biopioneer India, incubated at KIIT TBI in Odisha, is India’s first manufacturer of protease inhibitor. While most available protease inhibitors are imported, less effective, and require cold-chain logistics for transport and storage, Biopioneer addresses these limitations with its flagship product — NexGen HM™ Protease Inhibitor.

On the other hand, SpineX Inc. is a global, clinical-stage bioelectric medicine company transforming the treatment landscape for neurological disorders through non-invasive spinal cord neuromodulation. The company’s proprietary platform, xStep, is built to address a broad range of chronic neurological and metabolic conditions.

Clinexel works with investors to advise them on the key decision of investment, hand holding the biotech across the clinical development, designing milestones for funding, assessing the impact of external as well as internal environment, and developing strategies for timely exit.

After a thorough review and evaluation by the jury members, Biopioneer India emerged as the winner of the Best Startup Pitch award during the session.

Published on : 04th August, 2025